0001810326-20-000001.txt : 20200506 0001810326-20-000001.hdr.sgml : 20200506 20200506162426 ACCESSION NUMBER: 0001810326-20-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b ITEM INFORMATION: Investment Company Act Section 3(c) ITEM INFORMATION: Section 3(c)(1) ITEM INFORMATION: Section 3(c)(7) FILED AS OF DATE: 20200506 DATE AS OF CHANGE: 20200506 EFFECTIVENESS DATE: 20200506 FILER: COMPANY DATA: COMPANY CONFORMED NAME: MISSION BIOCAPITAL V LP CENTRAL INDEX KEY: 0001810326 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-366421 FILM NUMBER: 20852965 BUSINESS ADDRESS: STREET 1: 139 MAIN STREET, SUITE 401 CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 6172765578 MAIL ADDRESS: STREET 1: 139 MAIN STREET, SUITE 401 CITY: CAMBRIDGE STATE: MA ZIP: 02142 D 1 primary_doc.xml X0708 D LIVE 0001810326 MISSION BIOCAPITAL V LP 139 MAIN STREET, SUITE 401 CAMBRIDGE MA MASSACHUSETTS 02142 6172765578 DELAWARE None None Limited Partnership true 2020 - Mission BioCapital V GP LLC 139 Main Street Suite 401 Cambridge MA MASSACHUSETTS 02142 Promoter General Partner of the Issuer Pooled Investment Fund Venture Capital Fund false Decline to Disclose 06b 3C 3C.1 3C.7 false true false true false 0 Indefinite 0 Indefinite false 0 0 0 0 false MISSION BIOCAPITAL V LP /s/ Peter Parker Peter Parker Manager of the General Partner 2020-05-06